|
IFIT5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.157600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.160000E-01 |
| Normal-vs-Stage2 |
8.866600E-01 |
| Normal-vs-Stage3 |
2.032100E-02 |
| Normal-vs-Stage4 |
2.376100E-02 |
| Stage1-vs-Stage2 |
7.584600E-01 |
| Stage1-vs-Stage3 |
2.747700E-02 |
| Stage1-vs-Stage4 |
1.280770E-01 |
| Stage2-vs-Stage3 |
8.124200E-02 |
| Stage2-vs-Stage4 |
5.796300E-02 |
| Stage3-vs-Stage4 |
3.390600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.684800E-01 |
| Normal-vs-AfricanAmerican |
7.094600E-01 |
| Normal-vs-Asian |
1.618020E-01 |
| Caucasian-vs-AfricanAmerican |
5.128400E-01 |
| Caucasian-vs-Asian |
4.865600E-01 |
| AfricanAmerican-vs-Asian |
3.316600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.824790E-01 |
| Normal-vs-Female |
5.512800E-01 |
| Male-vs-Female |
8.363700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.570580E-01 |
| Normal-vs-Extreme_Weight |
3.060200E-01 |
| Normal-vs-Obese |
4.996400E-01 |
| Normal-vs-Extreme_Obese |
3.936000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.762200E-01 |
| Normal_Weight-vs-Obese |
3.253400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.250600E-01 |
| Extreme_Weight-vs-Obese |
6.963400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.092400E-01 |
| Obese-vs-Extreme_Obese |
7.101400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.855200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.967400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.348400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.379800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.794400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.090640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.970000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.013600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.391030E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.115200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.658000E-01 |
| Normal-VS-Type2 PRCC |
2.185800E-02 |
| Normal-VS-KIRP CIMP |
8.218200E-02 |
| Normal-VS-Unclassified PRCC |
5.952000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.051950E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.404000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.376000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.184600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.647720E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.123430E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.001800E-02 |
| Normal-vs-N1 |
1.644040E-01 |
| Normal-vs-N2 |
2.243500E-02 |
| N0-vs-N1 |
5.543600E-01 |
| N0-vs-N2 |
1.860980E-01 |
| N1-vs-N2 |
7.888000E-02 |
|
|
